RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 125 filers reported holding RELAY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,058,445 | -59.2% | 958,198 | -39.1% | 0.00% | -60.0% |
| Q2 2023 | $19,771,412 | +631776.4% | 1,574,157 | +728.5% | 0.01% | +400.0% |
| Q1 2023 | $3,129 | -66.7% | 190,000 | -69.8% | 0.00% | -60.0% |
| Q4 2022 | $9,403 | -99.0% | 629,336 | +1464.2% | 0.01% | +400.0% |
| Q3 2022 | $900,000 | -71.0% | 40,234 | -78.3% | 0.00% | -50.0% |
| Q2 2022 | $3,108,000 | +654.4% | 185,557 | +1248.5% | 0.00% | – |
| Q1 2022 | $412,000 | -36.2% | 13,760 | -34.6% | 0.00% | – |
| Q4 2021 | $646,000 | -26.2% | 21,033 | -24.2% | 0.00% | – |
| Q3 2021 | $875,000 | +10.2% | 27,758 | +20.9% | 0.00% | -100.0% |
| Q1 2021 | $794,000 | -72.6% | 22,958 | -67.1% | 0.00% | -50.0% |
| Q4 2020 | $2,897,000 | – | 69,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |